Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol for pericarditis
2025-523015-11-00Phase 3Authorised
- Sponsor
- Azienda sanitaria universitaria Friuli Centrale
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bisoprolol in pericarditis (2 arms), sponsored by Azienda sanitaria universitaria Friuli Centrale. Planned start Oct 2025; status: authorised.
02
Drugs
bisoprolol
03
Conditions
pericarditis
Beyond the preview
Go deeper on 2025-523015-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523015-11-00.